跳至主要内容
临床试验/ACTRN12608000122358
ACTRN12608000122358已完成未知

To compare the bone mineral density (BMD) of women who have used the levonorgestrel-releasing intra-uterine system Mirena for 4 to 6 years with women who have not been exposed to exogenous hormones or pregnancy for the previous 5 years.

niversity of Otago0 个研究点目标入组 68 人开始时间: 2008年3月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
30 Years 至 47 Years(—)
性别
Female

入选标准

  • Women 30 to 47 years old who have used a Mirena for 4 to 6 years (exposed group) and women who have not been exposed to exogenous hormones or pregnancy for the previous 5 years (control group).

排除标准

  • History of chronic illness, metabolic bone disease. Taking medications known to affect bone or mineral metabolism, or any other hormonal medication taken in the previous 5 years. Pregnancy in the previous 5 years.

研究者

相似试验